Everence Capital Management’s M.D.C. Holdings, Inc. MDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,555
Closed -$664K 761
2024
Q1
$664K Hold
10,555
0.04% 334
2023
Q4
$583K Hold
10,555
0.04% 354
2023
Q3
$435K Hold
10,555
0.03% 433
2023
Q2
$425K Hold
10,555
0.03% 400
2023
Q1
$410K Hold
10,555
0.03% 420
2022
Q4
$334K Hold
10,555
0.03% 499
2022
Q3
$289K Hold
10,555
0.03% 526
2022
Q2
$341K Hold
10,555
0.03% 470
2022
Q1
$399K Hold
10,555
0.03% 482
2021
Q4
$589K Hold
10,555
0.04% 354
2021
Q3
$493K Hold
10,555
0.04% 409
2021
Q2
$534K Hold
10,555
0.04% 374
2021
Q1
$627K Sell
10,555
-1
-0% -$52 0.06% 292
2020
Q4
$475K Hold
10,556
0.05% 354
2020
Q3
$460K Sell
10,556
-6,847
-39% -$273K 0.05% 323
2020
Q2
$548K Hold
17,403
0.06% 263
2020
Q1
$374K Hold
17,403
0.05% 319
2019
Q4
$615K Hold
17,403
0.09% 238
2019
Q3
$695K Hold
17,403
0.11% 194
2019
Q2
$528K Sell
17,403
-3,489
-17% -$103K 0.09% 244
2019
Q1
$562K Buy
+20,892
New +$553K 0.1% 220

Other funds holding MDC

Everence Capital Management's MDC Position: Q2 2024 in Review

Everence Capital Management sold out of M.D.C. Holdings, Inc. (MDC) in Q2 2024, closing a stake of 10,555 shares — an estimated $664K sold.

Everence Capital Management first reported a position in MDC in Q1 2019 and held it in 21 quarters. The position peaked at $695K in Q3 2019. 4 funds tracked by Wall St. Rank hold MDC as of Q2 2024.

  • Everence Capital Management reported no remaining M.D.C. Holdings, Inc. position as of Q2 2024 after selling out during the quarter.
  • Everence Capital Management sold 10,555 M.D.C. Holdings, Inc. shares in Q2 2024, an estimated $664K.
  • Everence Capital Management first reported a position in M.D.C. Holdings, Inc. in Q1 2019 and held it in 21 quarters.
  • Everence Capital Management's M.D.C. Holdings, Inc. position peaked at $695K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held M.D.C. Holdings, Inc. as of Q2 2024.

Based on Everence Capital Management's 13F filing for Q2 2024, filed 3 Jul 2024.